178 related articles for article (PubMed ID: 35392841)
1. Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial.
Wang M; Cui C; Sui Y; Yu SA; Ma JX; Fu AC
BMC Ophthalmol; 2022 Apr; 22(1):161. PubMed ID: 35392841
[TBL] [Abstract][Full Text] [Related]
2. Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial.
Wang M; Cui C; Yu SA; Liang LL; Ma JX; Fu AC
Front Pediatr; 2023; 11():1095495. PubMed ID: 36733432
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical atropine on astigmatism.
Chia A; Chua WH; Tan D
Br J Ophthalmol; 2009 Jun; 93(6):799-802. PubMed ID: 19211603
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
[TBL] [Abstract][Full Text] [Related]
5. Agreement between refractive and corneal astigmatism in pseudophakic eyes.
Tejedor J; Guirao A
Cornea; 2013 Jun; 32(6):783-90. PubMed ID: 23132451
[TBL] [Abstract][Full Text] [Related]
6. Predicting ocular residual astigmatism using corneal and refractive parameters: a myopic eye study.
Park CY; Oh JH; Chuck RS
Curr Eye Res; 2013 Aug; 38(8):851-61. PubMed ID: 23621376
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
8. Effects on radius of curvature and refractive power of the cornea and crystalline lens by atropine 0.01% eye drops.
Wang Y; Liu F; Zhu X; Liu Y; He JC; Zhou X; Qu X
Acta Ophthalmol; 2024 Feb; 102(1):e69-e77. PubMed ID: 37143398
[TBL] [Abstract][Full Text] [Related]
9. Evaluating internal and ocular residual astigmatism in Chinese myopic children.
Liu Y; Cheng Y; Zhang Y; Zhang L; Zhao M; Wang K
Jpn J Ophthalmol; 2017 Nov; 61(6):494-504. PubMed ID: 28983803
[TBL] [Abstract][Full Text] [Related]
10. Refractive, corneal and ocular residual astigmatism: distribution in a German population and age-dependency - the Gutenberg health study.
Schuster AK; Pfeiffer N; Schulz A; Hoehn R; Ponto KA; Wild PS; Blettner M; Beutel ME; Lackner KJ; Münzel T; Mirshahi A
Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2493-2501. PubMed ID: 28823075
[TBL] [Abstract][Full Text] [Related]
11. Correlation between ocular residual astigmatism and anterior corneal astigmatism in children with low and moderate myopia.
Lin J; An D; Lu Y; Yan D
BMC Ophthalmol; 2022 Sep; 22(1):374. PubMed ID: 36123634
[TBL] [Abstract][Full Text] [Related]
12. Atropine for the treatment of childhood myopia.
Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
[TBL] [Abstract][Full Text] [Related]
13. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
[TBL] [Abstract][Full Text] [Related]
14. Effects of atropine 0.01% on refractive errors in children with myopia.
Zhu X; Wang Y; Liu Y; Ye C; Zhou X; Qu X
Heliyon; 2023 Aug; 9(8):e18743. PubMed ID: 37576220
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of internal, refractive, and corneal astigmatism in a UK university student population.
Nagra M; Dashrathi R; Senthan E; Jahan T; Campbell P
Cont Lens Anterior Eye; 2020 Aug; 43(4):333-337. PubMed ID: 32094053
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal change in components of astigmatism and its association with axial length-corneal radius ratio in Chinese young children: the Nanjing Eye Study.
Li X; Li R; Shen S; Wang Z; Tong H; Huang D; Wang Y; Zhao X; Zhang X; Yan W; Wang Y; Zhao A; Chen D; Guo W; Zhang T; Shao X; Liu H; Zhu H
Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):335-343. PubMed ID: 34436647
[TBL] [Abstract][Full Text] [Related]
17. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
18. Corneal and lenticular components of total astigmatism in a preschool sample.
Shankar S; Bobier WR
Optom Vis Sci; 2004 Jul; 81(7):536-42. PubMed ID: 15252353
[TBL] [Abstract][Full Text] [Related]
19. Corneal power and astigmatism in Down syndrome.
Little JA; Woodhouse JM; Saunders KJ
Optom Vis Sci; 2009 Jun; 86(6):748-54. PubMed ID: 19390470
[TBL] [Abstract][Full Text] [Related]
20. Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.
Pérez-Flores I; Macías-Murelaga B; ; Barrio-Barrio J
Sci Rep; 2023 Sep; 13(1):16310. PubMed ID: 37770602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
